Fortis Healthcare Limited (NSE:FORTIS)
859.25
+1.80 (0.21%)
Aug 1, 2025, 3:30 PM IST
Exscientia Revenue
In the fiscal year ending March 31, 2025, Fortis Healthcare had annual revenue of 77.86B INR with 12.88% growth. Fortis Healthcare had revenue of 20.11B in the quarter ending March 31, 2025, with 12.30% growth.
Revenue
77.86B
Revenue Growth
+12.88%
P/S Ratio
8.33
Revenue / Employee
6.36M
Employees
12,237
Market Cap
648.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 77.86B | 8.89B | 12.88% |
Mar 31, 2024 | 68.97B | 6.00B | 9.52% |
Mar 31, 2023 | 62.98B | 5.80B | 10.14% |
Mar 31, 2022 | 57.18B | 16.87B | 41.87% |
Mar 31, 2021 | 40.30B | -6.02B | -13.00% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Fortis Healthcare News
- 10 days ago - Fortis Healthcare signs operation & maintenance deal with Gleneagles Healthcare India for 5 hospitals and 1 clinic - Business Upturn
- 4 months ago - Fortis Healthcare in focus: Subsidiary receives Rs 76.19 crore income tax demand for FY2019 - Business Upturn
- 4 months ago - Fortis Healthcare secures full ownership of ‘Fortis’ trademark for Rs 200 crore after Delhi High Court approval - Business Upturn
- 4 months ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 4 months ago - Fortis Healthcare receives injunction order related to Shrimann Hospital acquisition - Business Upturn
- 6 months ago - Fortis Healthcare subsidiary acquires Shrimann Superspecialty Hospital in Jalandhar for Rs 461.9 crore - Business Upturn
- 6 months ago - What to buy and sell today (February 10): M&M, SBI, Fortis among top picks, LIC & Ola Electric in focus - Business Upturn
- 6 months ago - Nomura on Fortis Health: Buy call, target at Rs 700, sees 8% upside on strong hospital revenue - Business Upturn